Research has found that long-term use of type 2 diabetes drug liraglutide caused degenerative weakening of insulin-producing cells. Liraglutide is an FDA-approved drug marketed as Victoza used for treating the condition alongside an exercise and diet regimen.
Research has found that long-term use of type 2 diabetes drug liraglutide caused degenerative weakening of insulin-producing cells. Liraglutide is an FDA-approved drug marketed as Victoza used for treating the condition alongside an exercise and diet regimen.
Share this Article
Recommended